Program Evaluation

We evaluated both the Center for Medicare and Medicaid Services Innovation Center (CMS Innovation Center) models and the Medicare Shared Savings Program (MSSP) and found that they have generated gross savings for all beneficiaries in the Traditional Medicare program while demonstrating positive impacts on selected quality measures.

The Inflation Reduction Act (IRA) changes the way Medicare pays for prescription drugs. These changes will impact various stakeholders, including Medicare, Medicare enrollees, drug manufacturers, and others.

This ASPE issue brief lays out a proposed comprehensive analytic framework to fully evaluate the impact of the CMS Innovation Center’s efforts on the Medicare program and the broader health care system as a whole to test innovative payment and service delivery models that reduce program expenditures while preserving or enhancing the quality of care.

National estimates indicate that streamlined renewal options for Medicaid beneficiaries with incomes below 100 percent of the federal poverty level and without an ex parte income data source would provide timely and accurate eligibility determinations.

The Office of the Assistant Secretary for Planning and Evaluation (ASPE) released a report summarizing lessons learned from using communities of practice (CoPs) to support state, Tribal, local, and territorial (STLT) public health agencies during the COVID-19 pandemic.

Assisted outpatient treatment (AOT) is a civil court procedure whereby a judge orders an adult with serious mental illness (SMI) to comply with community-based treatment. Developed as a less restrictive alternative to involuntary hospitalization, AOT focuses on individuals at risk of clinical deterioration or rehospitalization because they do not voluntarily comply with prescribed treatment.

The calculation of behavioral health quality measures at the clinic level holds great promise for monitoring clinic performance over time, and for providing information for clinics to use to revise their processes and procedures to improve their performance.

The FY 2025 HHS Evaluation Plan details the Department of Health and Human Services’ (HHS) efforts to answer the priority questions presented in the current HHS Evidence Building Plan. This plan provides both an overview of HHS evaluation activities planned for FY 2025 and detailed information for each new and continuing evaluation effort.

The U.S. Department of Health and Human Services (HHS) analyzes the benefits, costs, and other impacts of significant proposed and final rulemakings, consistent with the requirements of several executive orders and statutes. HHS develops these analyses according to technical guidance published by the U.S.

The Fiscal Year (FY) HHS 2024 Evaluation plan lists a total of thirty-two (32) evaluations from ten (10) Operating and Staff Divisions across the U.S. Department of Health and Human Services (HHS).